Outcomes Among Clopidogrel, Prasugrel, and Ticagrelor in ST-Elevation Myocardial Infarction Patients Who Underwent Primary Percutaneous Coronary Intervention From the TOTAL Trial-Reference-Cited by-同舟云学术

Outcomes Among Clopidogrel, Prasugrel, and Ticagrelor in ST-Elevation Myocardial Infarction Patients Who Underwent Primary Percutaneous Coronary Intervention From the TOTAL Trial

Published:2019-10 Issue:10 Volume:35 Page:1377-1385
ISSN:0828-282X
Container-title:Canadian Journal of Cardiology
language:en
Short-container-title:Canadian Journal of Cardiology

Author:

Welsh Robert C.^ORCID,Sidhu Robinder S.^ORCID,Cairns John A.,Lavi Shahar,Kedev Sasko,Moreno Raul,Cantor Warren J.,Stankovic Goran,Meeks Brandi,Yuan Fei,Džavík Vladimír^ORCID,Jolly Sanjit S.^ORCID

Funder

Canadian Institutes of Health Research

Canadian Network and Centre for Trials International

Medtronic

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference33 articles.

1. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

2. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines;O’Gara;J Am Coll Cardiol,2013

3. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation;Yusuf;N Engl J Med,2001